Walden Biosciences
Biotech
- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1120 | XGENOMES CORP. | — | — |
| 1121 | LYTICON, LLC | — | — |
| 1122 | Sana Biotechnology | — | $867M |
| 1123 | Walden Biosciences | — | — |
| 1124 | Kriya Therapeutics | — | $769M |
| 1125 | VERSATOPE THERAPEUTICS, INC. | — | — |
| 1126 | Inhibrx, Inc. | — | $669M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Dynamin Activatorsapplication
- Novel Soluble Urokinase Plasminogen Activator Receptor (supar) Binding Molecules And Uses Thereofapplication
- Method Of Administering An Anti-soluble Urokinase Plasominogen Activator Receptor Antibody For The Treatment Of Kidney Diseaseapplication
- Method Of Administering An Anti-soluble Urokinase Plasominogen Activator Receptor Antibody For The Treatment Diabetic Nephropathyapplication
- Dynamin Activatorsapplication
- Novel Soluble Urokinase Plasminogen Activator Receptor (supar) Binding Molecules And Uses Thereofapplication
- Dynamin Activatorsapplication
- Method Of Administering An Anti-soluble Urokinase Plasominogen Activator Receptor Antibody For The Treatment Of Kidney Diseaseapplication
- SOLUBLE UROKINASE PLASMNOGEN ACTIVATOR RECEPTOR (suPAR) BINDING MOLECULES AND USES THEREOFapplication
- Method Of Administering An Anti-soluble Urokinase Plasominogen Activator Receptor Antibody For The Treatment Of Kidney Diseaseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.